JP2020537517A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020537517A5 JP2020537517A5 JP2020519402A JP2020519402A JP2020537517A5 JP 2020537517 A5 JP2020537517 A5 JP 2020537517A5 JP 2020519402 A JP2020519402 A JP 2020519402A JP 2020519402 A JP2020519402 A JP 2020519402A JP 2020537517 A5 JP2020537517 A5 JP 2020537517A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- nucleic acid
- recombinant
- specific polarization
- expression vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762568786P | 2017-10-05 | 2017-10-05 | |
| US62/568,786 | 2017-10-05 | ||
| PCT/US2018/054451 WO2019071032A2 (en) | 2017-10-05 | 2018-10-04 | MULTIVALENT ANTIGENS STIMULATING TH1 AND TH2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020537517A JP2020537517A (ja) | 2020-12-24 |
| JP2020537517A5 true JP2020537517A5 (cg-RX-API-DMAC7.html) | 2021-02-12 |
Family
ID=65994804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020519402A Pending JP2020537517A (ja) | 2017-10-05 | 2018-10-04 | Th1及びth2を刺激する多価抗原 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200331976A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3692055A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2020537517A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200055136A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111417648A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018346511A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3077424A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019071032A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110298124B (zh) * | 2019-07-03 | 2020-10-27 | 江南大学 | 一种基于滤波的工业控制系统执行器参数估计方法 |
| US11130787B2 (en) | 2020-06-11 | 2021-09-28 | MBF Therapeutics, Inc. | Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100773109B1 (ko) * | 1999-05-06 | 2007-11-02 | 웨이크 포리스트 유니버시티 | 면역 반응을 유발하는 항원을 동정하기 위한 조성물과 방법 |
| DE60038622D1 (de) * | 1999-10-20 | 2008-05-29 | Univ Johns Hopkins Med | Chimäre immunogene zusammensetzungen und dafür kodierende nukleinsäure |
| WO2001094419A2 (en) * | 2000-06-07 | 2001-12-13 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Method to induce the th1 immune response |
| ES2404689T3 (es) * | 2001-04-05 | 2013-05-28 | The Johns Hopkins University | Vacunas quiméricas que comprenden el dominio lumenal de LAMP-1 o LAMP-2 |
| US9592284B2 (en) * | 2004-04-28 | 2017-03-14 | The Trustees Of The University Of Pennsylvania | Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boost |
| CA2760041A1 (en) * | 2008-05-14 | 2009-11-19 | Simons Haplomics Limited | Methods and compositions for the treatment of cancer |
| US9795661B2 (en) * | 2009-11-16 | 2017-10-24 | The United States Of America As Represented By The Secretary Of The Navy | TH1/TH2 polarizing vaccines |
| EA025280B1 (ru) * | 2010-03-09 | 2016-12-30 | Амир Максютов | Полиэпитопные конструкции и способы их получения и применения |
| EP3027205A4 (en) * | 2013-07-28 | 2017-07-19 | Qantu Therapeutics, Inc. | Vaccine formulations that induce a th2 immune response |
| CN108601820A (zh) * | 2015-10-12 | 2018-09-28 | 南托米克斯有限责任公司 | 用于病毒癌症新表位的组合物和方法 |
| JP2019513021A (ja) * | 2016-03-24 | 2019-05-23 | ナントセル,インコーポレイテッド | ネオエピトープ提示のための配列の配置および配列 |
-
2018
- 2018-10-04 EP EP18864160.9A patent/EP3692055A4/en not_active Withdrawn
- 2018-10-04 US US16/753,272 patent/US20200331976A1/en not_active Abandoned
- 2018-10-04 AU AU2018346511A patent/AU2018346511A1/en not_active Abandoned
- 2018-10-04 KR KR1020207012938A patent/KR20200055136A/ko not_active Withdrawn
- 2018-10-04 CA CA3077424A patent/CA3077424A1/en not_active Abandoned
- 2018-10-04 WO PCT/US2018/054451 patent/WO2019071032A2/en not_active Ceased
- 2018-10-04 CN CN201880077146.2A patent/CN111417648A/zh not_active Withdrawn
- 2018-10-04 JP JP2020519402A patent/JP2020537517A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiao et al. | CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy | |
| Draper et al. | Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6 | |
| ES2836273T3 (es) | Método para el tratamiento del cáncer | |
| US12311018B2 (en) | Targeted neoepitope vectors and methods therefor | |
| AU2017233072B2 (en) | Multimodal vector for dendritic cell infection | |
| JP2017525336A5 (cg-RX-API-DMAC7.html) | ||
| JP2018509135A5 (cg-RX-API-DMAC7.html) | ||
| JP2019513021A (ja) | ネオエピトープ提示のための配列の配置および配列 | |
| US20210369825A1 (en) | Cd40 and cd40l combo in an adv vaccine vehicle | |
| JP2018509163A5 (cg-RX-API-DMAC7.html) | ||
| JP2019508044A5 (cg-RX-API-DMAC7.html) | ||
| JP2010534463A5 (cg-RX-API-DMAC7.html) | ||
| JP2019524773A (ja) | 樹状細胞のトランスフェクション及びその方法 | |
| JP2019509265A5 (cg-RX-API-DMAC7.html) | ||
| JP2013176373A (ja) | T細胞レセプターβ鎖遺伝子及びα鎖遺伝子 | |
| US20210032371A1 (en) | Enhanced Immunogenicity For GPI-anchored Antigens | |
| Drakes et al. | Lymph node–targeted vaccine boosting of TCR T-cell therapy enhances antitumor function and eradicates solid tumors | |
| Bellone et al. | Advances in dendritic cell-based therapeutic vaccines for cervical cancer | |
| Shah et al. | What do cancer-specific T cells ‘see’? | |
| JP2022532271A5 (cg-RX-API-DMAC7.html) | ||
| FI3236985T4 (fi) | Uusia peptidejä ja peptidien yhdistelmiä käytettäväksi immunoterapiassa hepatosellulaarista karsinoomaa (hcc) ja muita syöpiä vastaan | |
| US20200331976A1 (en) | Multivalent Antigens Stimulating TH1 and TH2 | |
| Bhojnagarwala et al. | synDNA vaccine against TCR chains and neoantigens for T cell lymphoma therapy | |
| Jung et al. | 1421 Th1-specific epitope selection for an off-the-shelf type KRAS cancer vaccine: epitopes of non-mutated lesion | |
| Shah et al. | What do cancer-specific T cells ‘see’? |